글로벌 심혈관 수리 및 재건 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

Grand View Research에 따르면, 글로벌 심혈관 수리 및 재건 장치 시장은 2025년까지 4,481.5백만 달러에 도달할 것으로 추산됩니다. 예측 기간 동안 선천적 심장 결손(CHD)의 증가와 기술적으로 향상된 심혈관 판막, 이식편 및 패치의 가용성이 성장을 촉진할 가능성이 높습니다.

Data Bridge Market Research는 2021년에 37억 2천만 달러였던 심혈관 수리 및 재건 시장이 2029년까지 60억 6천만 달러로 급증할 것으로 분석했으며, 2022년부터 2029년까지 예측 기간 동안 6.30%의 CAGR을 보일 것으로 예상합니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화

시장 정의

Heart disorders such as congenital heart disease, coronary artery disease, and arrhythmias are examples of cardiovascular diseases. Blockages in blood arteries can cause chest discomfort and heart attacks. Men are more likely than women to have chest discomfort as a symptom of cardiovascular disease, whereas women may experience symptoms such as excessive exhaustion, shortness of breath, and nausea. Blockages in arteries and veins are removed using cardiovascular reconstruction devices.

Cardiovascular Repair and Reconstruction Market Dynamics

Drivers

• Rise in cardiac diseases

According to the American Heart Association, cardiovascular diseases (CVDs) were a leading cause of death in the United States in 2015, accounting for approximately 800,000 fatalities. In the United States, about 85.6 million people are affected by the effects of a stroke or another type of CVD. It is one of the leading causes of death in the world. CVDs claimed the lives of almost 17.7 million individuals in 2015, accounting for roughly 31% of all fatalities worldwide. Mild CHD is becoming more common in the United States. Over a quarter of babies with CHD develop catastrophic CHD in their first year, which requires surgery or medication to cure. As a result, the cardiovascular repair and reconstruction market is expected to increase significantly throughout the forecast period.

• Technological advancements

New technologically advanced products, product designs, raw material procurement, raw material production, clinical evaluation, preservation solutions, and preservation procedures have all been produced. Consider the usage of ePTFE in the fabrication of cardiovascular patches by Gore Medical. ePTFE patches are strengthening the cardiovascular repair and reconstruction industry as their use for various cardiovascular repair devices grows.

• Improvement of cryopreservation procedures

Cryopreservation procedures that are technologically improved also contribute to the growth of the cardiovascular repair devices market. They aid in preserving raw materials collected from animal tissues for a longer period of time, which is critical in extending their life cycle. These technological advancements are helping to drive market growth by increasing demand for cardiovascular grafts and patches.

Opportunities

Tissue valve demand has increased since the introduction of transcatheter valves. TAVI (Transcatheter Aortic Valve Implantation) or TAVR (Transcatheter Aortic Valve Replacement) is an FDA-approved procedure for treating symptomatic aortic stenosis with a heart valve replacement. The TAVR market is dominated by established players like Edwards Lifesciences and Medtronic. In addition, JenaValve, a German business, successfully enrolled for the CE mark study for the next-generation JenaValve Pericardial TAVR system in April 2018, and is planning a restricted launch in a select European areas and countries compatible with the CE mark in the coming quarters. In the next years, new companies with innovative technologies will significantly enhance market growth.

Restraints/Challenges

The danger of skin infections is predicted to impede market expansion throughout the forecast period. The high cost of cardiovascular repair and reconstruction products and a lack of understanding about microbe-derived items are predicted to hinder market expansion over the forecast period of 2022 to 2029.

This cardiovascular repair and reconstruction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cardiovascular repair and reconstruction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 impact on Cardiovascular Repair and Reconstruction Market

During the first half of 2020, the COVID-19 had a negative impact on the worldwide cardiovascular surgical devices business. The World Health Organization recognized the emergence of healthcare with the outbreak of Covid-19 (WHO). Furthermore, the governments instituted a nationwide lockdown and a flight restriction. Furthermore, cardiac surgery activities were halted and postponed due to the unexpected shutdown, causing the market to fall. However, the market has grown significantly in the aftermath of the pandemic. Furthermore, heart surgery usage has increased, and the market has grown at the fastest rate. With the arrival of the year 2021, market shares are predicted to increase on average.

Recent Development

• In October 2020, GE Healthcare got FDA 510k clearance for its ultra-edition bundle of vivid cardiovascular ultrasound devices, which includes new AI-based capabilities that allow doctors to consistently obtain faster, more reproducible assessments.

Global Cardiovascular Repair and Reconstruction Market Scope

The cardiovascular repair and reconstruction market is segmented on the basis of product, raw material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Heart Valve Repair
• Cardiovascular Grafts
• Endovascular stent graft
• Hemodialysis access graft
• Peripheral vascular graft
• Cardiovascular Patches

 Application

• Cardiac repair patches
• Atrial septal defect
• Common atrium
• Defects of the endocardial cushion
• Ventricular septal defect
• Tetralogy of Fallot
• Suture bleeding
• Vascular Repair Patches
• Carotid endarterectomy
• Anomalous connection of the pulmonary veins
• Transportation of the great vessels
• Reconstruction of the portal and superior mesenteric veins
• Others

Raw Material

• Synthetic patches
• Biological patches

Cardiovascular Repair and Reconstruction Market Regional Analysis/Insights

The cardiovascular repair and reconstruction market is analysed and market size insights and trends are provided by country, product, raw material and application as referenced above.

The countries covered in the cardiovascular repair and reconstruction market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the global cardiovascular repair and reconstruction market. Because of the ageing population and bad lifestyle, cardiovascular illnesses are prevalent.

Asia-Pacific is expected to witness the fastest growth over the forecast period. Due to their vast populations, ageing populations, high unmet healthcare requirements, and changing lifestyles, China, India, and other growing nations in the region are at the forefront. Improvements in the region's healthcare infrastructure are also helping to drive the market forward.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 심혈관 수리 및 재건 시장 점유율 분석

심혈관 복구 및 재건 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 심혈관 복구 및 재건 시장과 관련된 회사의 초점에만 관련이 있습니다.

심혈관 복구 및 재건 시장에서 활동하는 주요 업체는 다음과 같습니다.

• CryoLife, Inc. (미국)
• 에드워즈 라이프사이언스 코퍼레이션(미국)
• 바드 말초혈관(미국)
• 백스터(미국)
• 안테리스(미국)
• Neovasc Inc. (캐나다)
• Southernlight Biomaterials (뉴질랜드)
• 메드트로닉(아일랜드)
• 게팅게 AB(스웨덴)
• WL Gore & Associates, Inc. (미국)
• 애벗(미국)
• LeMaitre Vascular Inc. (미국)
• BioIntegral Surgical (캐나다)
• Laboratory Corporation of America Holdings (미국)
• 테루모 메디컬 코퍼레이션(미국)
• 페루즈 메디컬(프랑스)
• 군제 리미티드(미국)
• Maverick Biosciences (미국)

SKU-68650